Rhythm Biosciences Limited (ASX:RHY)

$1.67

right-arrow Created with Sketch. 0.18 (12.08%)
MCAP $311.2M
Last trade 16.10pm 07/12/2021 20mins delayed

Latest Announcements

02/12/2021RHYRhythm Biosciences Limited
169
MCap
02/12/2021RHYRhythm Biosciences Limited
01/12/2021RHYRhythm Biosciences Limited
01/12/2021 Price SensitivePSRHYRhythm Biosciences Limited
30/11/2021 Price SensitivePSRHYRhythm Biosciences Limited
25/11/2021RHYRhythm Biosciences Limited
25/11/2021RHYRhythm Biosciences Limited
24/11/2021RHYRhythm Biosciences Limited
170
MCap

Company Overview

Rhythm Biosciences Limited is a medical diagnostics technology company. The Company is engaged in developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. The Company’s development stage product, ColoSTAT focuses to provide early detection test for colorectal cancer. The Company’s ColoSTAT blood test is used to detect colorectal cancer at all stages, including the early ones. The Company's subsidiary includes Vision Tech Bio Pty Ltd.

RHY in the news

Rhythm Biosciences (RHY) restructures board and management team, effective immediatelyCurrent Chair Otto…
Cancer diagnostic technology company Rhythm Biosciences (RHY) achieves CE Mark certification for…
Cancer diagnostics technology company Rhythm Biosciences (RHY) updates the market regarding the…
Rhythm Biosciences (RHY) completes recruitment for its clinical trial for detecting colorectal…

Search Previous Announcements